Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism of debrisoquine oxidation in New Zealand Caucasians.

European journal of clinical pharmacology - 1 Jan 1992

Wanwimolruk S, Denton J R, Ferry D G, Beasley M, Broughton J R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Chromatography, High Pressure Liquid
Share to Debrisoquin
Share to New Zealand

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Oxidation-Reduction

Share to Phenotype

Share to Polymorphism, Genetic

Share to White People

Source

Identifiers

PMID: 1577057
DOI: 10.1007/BF00266364

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism of debrisoquine oxidation in New Zealand Caucasians.PMID 1577057Read ↗

Molecular genetics of the debrisoquin-sparteine polymorphism.Semantic proximity Read ↗

Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.Semantic proximity Read ↗

Debrisoquine and N-acetylation polymorphism in Syria.Semantic proximity Read ↗

Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.Semantic proximity Read ↗

Genetically determined polymorphisms in drug oxidation.Semantic proximity Read ↗

Interpretation of a simple PCR analysis of the CYP2D6(A) and CYP2D6(B) null alleles associated with the debrisoquine/sparteine genetic polymorphism.Semantic proximity Read ↗

[The genetically determined polymorphism of metabolic oxidation of the sparteine-debrisoquin type].Semantic proximity Read ↗

[Clinical sequelae of genetically determined polymorphisms of drug oxidation].Semantic proximity Read ↗

Polymorphic debrisoquin metabolism in a Turkish population.Semantic proximity Read ↗

Dinucleotide repeat polymorphism at the debrisoquine 4-hydroxylase (CYP2D) locus.Semantic proximity Read ↗

Genetically determined adverse drug reactions involving metabolism.Semantic proximity Read ↗

Evidence for the polymorphic oxidation of debrisoquine in the Thai population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.